Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1

Wieslaw M. Kazmierski, Christopher Aquino, Brian A. Chauder, Felix Deanda, Robert G. Ferris, Deborah K. Jones-Hertzog, Terrence Kenakin, Cecilia S. Koble, Christian Watson, Pat Wheelan,

Journal of Medicinal Chemistry · 2008 · 32 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

We describe robust chemical approaches toward putative CCR5 scaffolds designed in our laboratories. Evaluation of analogues in the (125)I-[MIP-1beta] binding and Ba-L-HOS antiviral assays resulted in the discovery of 64 and 68 in the 4,4-disubstitited piperidine class H, both potent CCR5 ligands (pIC 50 = 8.30 and 9.00, respectively) and HIV-1 inhibitors (pIC 50 = 7.80 and 7.84, respectively, in Ba-L-HOS assay). In addition, 64 and 68 were bioavailable in rodents, establishing them as lead molecules for further optimization toward CCR5 clinical candidates.

References

9